Breaking News, Promotions & Moves

Biogen Names President and CEO

Christopher Viehbacher previously served as global CEO of Sanofi for six years.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Biogen has appointed Christopher A. Viehbacher as President and Chief Executive Officer and a member of the Board of Directors, effective November 14. Viehbacher succeeds Michel Vounatsos, who has led the company since 2017.   Viehbacher has extensive international experience in both large pharmaceutical companies and entrepreneurial biotech companies. Following 20 years with GlaxoSmithKline, he served as global CEO of Sanofi for six years, during which time the company overcame the loss ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters